General Information of Drug (ID: DMSGNM1)

Drug Name
Sideroxylonal C Drug Info
Synonyms sideroxylonal C; CHEMBL453538; BDBM50241601
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
10413640
TTD Drug ID
DMSGNM1

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
THR-18 DMBO021 Asthma CA23 Phase 2 [2]
DIAPLASININ DM6OJI1 Thrombosis DB61-GB90 Phase 1 [3]
XR-5118 DMIK72F Solid tumour/cancer 2A00-2F9Z Terminated [4]
AR-HO29953XX DM2PRHX Discovery agent N.A. Investigative [5]
SIDEROXYLONAL B DMDP7Y5 Discovery agent N.A. Investigative [1]
SIDEROXYLONAL A DMEIBTY Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 6 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Endothelial plasminogen activator inhibitor (SERPINE1) TTTO43N PAI1_HUMAN Inhibitor [1]

References

1 Sideroxylonal C, a new inhibitor of human plasminogen activator inhibitor type-1, from the flowers of Eucalyptus albens. J Nat Prod. 1999 Feb;62(2):324-6.
2 THR-18, a 18-mer peptide derived from PAI-1, is neuroprotective and improves thrombolysis by tPA in rat stroke models. Neurol Res. 2011 Nov;33(9):983-90.
3 Effect of the small molecule plasminogen activator inhibitor-1 (PAI-1) inhibitor, PAI-749, in clinical models of fibrinolysis. J Thromb Haemost. 2010 Jun;8(6):1333-9.
4 Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: design, synthesis, and preclinical characterization. J Med Chem. 2004 Jul 1;47(14):3491-4.
5 Synthesis and SAR of 2-carboxylic acid indoles as inhibitors of plasminogen activator inhibitor-1. Bioorg Med Chem Lett. 2005 Aug 1;15(15):3514-8.